SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $30,590,000 | -9.9% | 353,603 | -36.3% | 0.18% | -17.3% |
| Q3 2020 | $33,951,000 | +45.2% | 555,473 | -1.2% | 0.22% | +36.6% |
| Q2 2020 | $23,387,000 | +90.8% | 562,457 | +31.8% | 0.16% | +49.1% |
| Q1 2020 | $12,255,000 | -31.3% | 426,692 | +72.6% | 0.11% | -15.0% |
| Q4 2019 | $17,846,000 | -13.4% | 247,209 | +68.2% | 0.13% | -23.0% |
| Q3 2019 | $20,617,000 | – | 146,961 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |